January 2020
Volume 33, No. 1 |
|
|
|
|
|
|
| COVER STORY |
Rita C. Peters
Achieving effective manufacturing processes and sufficient capacity remains a top priority across a diversified biologic drug pipeline.
read more
| EMPLOYMENT SURVEY |
Rita C. Peters
With a positive employment market, some biopharma professionals explore options for career advancement.
read more
| UPSTREAM PROCESSING |
Feliza Mirasol
Industry experts debate the pros and cons of “going bigger” than the 2000-L industry norm in a single vessel.
read more
|
|
|
| BioPharm International January Issue
|
advertisement
|
|
| DOWNSTREAM PROCESSING |
Feliza Mirasol
Temperature-sensitive biologics are lyophilized to preserve therapeutic viability, but the process presents complexities and challenges that are as yet not fully understood.
read more
| MANUFACTURING |
Cynthia A. Challener
While cell and gene therapies differ in many ways, some of the best practices for process development and validation are similar.
read more
| PEER-REVIEWED RESEARCH |
Satabdi Rautray, A. Usha Rajananthini
This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.
read more
| QUALITY/REGULATIONS |
Agnes Shanley
Focusing on symptoms instead of root causes locks teams into a corrective, rather than preventive, mindset.
read more
|
|
|
|
| FROM THE EDITOR |
Rita C. Peters
The promise of new therapies is tempered by the need for affordability, safety, and ethics.
read more
| REGULATORY BEAT |
Jill Wechsler
Pressures on FDA will affect industry’s success in bringing new therapies to market.
read more
|
|
| EVENTS |
January 20-21, 2020
February 18–20, 2020
February 23–26, 2020
more events
|
|
|
|
|
|
Learn More ››
Register Now